Cancer burden in Nepal, 1990–2017: An analysis of the Global Burden of Disease study

Shrestha, Gambhir; Thakur, Rahul Kumar; Singh, Rajshree; Mulmi, Rashmi; Shrestha, Abha; Pradhan, Pranil Man Singh

doi:10.1371/journal.pone.0255499

Cited by 26 publications

(25 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 This amounts to 10% of total deaths in Nepal. 3 However, adequate resources to address this growing cancer burden are lacking. In a previous report, the lack of trained cancer care providers was recognized as one of the most prominent challenges to providing high-quality cancer care in Nepal.…”

Section: Introductionmentioning

confidence: 99%

Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal

Gyawali

Thapa

Savage

et al. 2022

JCO Global Oncology

View full text Add to dashboard Cite

PURPOSE Nepal lacks enough cancer care providers to address the growing burden of cancer in the country. One way of addressing this issue is to train general practitioners (GPs) in oncology (GPOs) so that they can task-share and task-shift oncology care. However, limited information is available regarding the current level of oncology expertise of Nepali GPs and whether they perceive a need for, and have an interest in, such a GPO training program if available in Nepal. METHODS A survey was distributed to GPs in Nepal to collect data on current oncology training and clinical practice and evaluate levels of interest and need for a GPO training program. The survey was distributed electronically from February to July 2021. RESULTS The survey obtained 71 individual responses from GPs in Nepal. The majority of respondents were male (87%), and most worked as consultants or senior consultants (63%). Only 6% of respondents had a mandatory oncology rotation during their GP training, and only 15% indicated that their GP training had adequately prepared them to care for patients with cancer. Ninety-six percent of respondents perceived a need for a GPO training program in Nepal, with 94% indicating an interest in enrolling in such a program and 71% indicating that they were very interested. CONCLUSION The findings indicate an urgent need for and an encouraging interest in establishing a GPO training program in Nepal. These findings will be used to guide the development and implementation of this type of program.

show abstract

Section: Introductionmentioning

confidence: 99%

Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal

Gyawali

Thapa

Savage

et al. 2022

JCO Global Oncology

View full text Add to dashboard Cite

show abstract

“…In a systematic analysis for the Global Burden of Disease Study 2019, there were an estimated 23.6 million new cancer cases and 10.0 million cancer deaths globally, with an estimated 250 million (235–264 million) Disability-Adjusted Life-Years (DALYs) due to cancer [ 16 ]. Cancer is a significant public health issue in Nepal, accounting for 10% of all fatalities [ 19 , 20 ]. To date, both the incidence and mortality of cancer are increasing in Nepal, negatively impacting DALYs.…”

Section: Rationale For Studymentioning

confidence: 99%

Clinical pharmacists’ intervention on pain management in cancer patients (PharmaCAP trial): study protocol for a randomized controlled trial

Shrestha

Blebil

Teoh

et al. 2023

J of Pharm Policy and Pract

View full text Add to dashboard Cite

Introduction Evidence-based services to support cancer patients with pain via clinical pharmacy services are currently lacking. Therefore, there is a need to undertake a randomized controlled trial (RCT) to explore the effectiveness of clinical pharmacists (CPs)’ input into the multidisciplinary team (MDT) in providing better therapeutic outcomes for cancer pain management. Objectives The main aim of this pilot RCT is to determine the feasibility and preliminary efficacy of integrating CPs into the MDT for cancer pain management on the clinical outcomes of cancer patients experiencing pain. Methods This study protocol outlines two-armed multicenter pilot RCT. Cancer patients suffering from pain will be randomly allocated to receive either clinical pharmacy services, i.e., PharmaCAP trial intervention from the CP, or the usual standard care (i.e., control group). Patients will be recruited consecutively from two hospitals in Kathmandu valley, Nepal. The outcomes will be assessed at baseline (pre-intervention) and 4 weeks post-intervention. The primary feasibility outcomes will include eligibility rate, recruitment rate, willingness to participate, acceptability of screening procedures and random allocation, possible contamination between the groups, intervention fidelity and compliance, treatment satisfaction, and patient understanding of the provided interventions. Subsequently, the primary clinical outcome, i.e., pain intensity of cancer patients, will be assessed. The secondary clinical outcomes will include health-related quality of life (HRQoL), anxiety, depression, adverse drug reactions, and patient medication compliance following the integration of CP into the healthcare team. Discussion The feasibility and potential for integrating CP involvement in MDT to improve clinical outcomes of cancer patients with pain will be evaluated through the PharmaCAP trial. Trial registration: ClinicalTrials.gov NCT05021393. Registered on 25th August 2022.

show abstract

“…From the year 1990 to 2017, the incidence of cancer and cancer-related deaths has increased by 92 and 95% respectively. Adoption of a sedentary lifestyle, consumption of tobacco, poor air quality, and lack of awareness are the major risk factors [1]. Common cancers prevalent in Nepal are breast, lung, cervical, and head and neck cancers, which all require radiotherapy (RT) at some point during illness [2].…”

Section: Introductionmentioning

confidence: 99%

Challenges and Prospects for Providing Radiotherapy Services in Nepal

Chawla¹,

Thakur²

2022

IJCOCR

View full text Add to dashboard Cite

In Nepal, the incidence of cancer in both males and females increased drastically in the last decade and is predicted to increase as well in the near future. The increase in Cancer burden could be a serious concern due to an underdeveloped national cancer control program. Around 50-60% of cancer patients require radiotherapy at some point during their illness which establishes it as an integral component of comprehensive cancer care. The current status of radiation facilities in the country is so scarce that it will be impossible to address the issue with available resources. It is high time for the authority to formulate a national cancer control program including the development of radiotherapy equipment and human resources. This article discusses the number of radiotherapy facilities, available equipment, and trained manpower in Nepal. Whether the available facilities are as per standard recommendation and will those be enough to handle the increasing load of cancer patients requiring radiotherapy in the future has been emphasized. Along with those challenges, the opportunities for developing radiotherapy facilities in Low Middle-Income countries like Nepal have been stressed out.

show abstract

Cancer burden in Nepal, 1990–2017: An analysis of the Global Burden of Disease study

Cited by 26 publications

References 34 publications

Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal

Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal

Clinical pharmacists’ intervention on pain management in cancer patients (PharmaCAP trial): study protocol for a randomized controlled trial

Challenges and Prospects for Providing Radiotherapy Services in Nepal

Contact Info

Product

Resources

About